Let’s recap the last 12 hours at Rockwell Medical (RMTI) when crazytown came to visit.
On Tuesday night, the drug maker’s board of directors fired CEO Robert Chioini. Then, as the sun rose on Wednesday morning, Chioini unfired himself, alleging board members may have violated federal securities laws.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
